O slideshow foi denunciado.
Seu SlideShare está sendo baixado. ×

TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal: Advancing Patient-Centered Care to Make the Most of Modern Targeted Treatments

Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio

Confira estes a seguir

1 de 117 Anúncio

TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal: Advancing Patient-Centered Care to Make the Most of Modern Targeted Treatments

Baixar para ler offline

Chair, Professor Peter Schmid, FRCP, MD, PhD, Carlos H. Barrios, MD, Eva M. Ciruelos, MD, PhD, and Hope S. Rugo, MD, FASCO, discuss Breast Cancer in this CME/MOC activity titled “TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal: Advancing Patient-Centered Care to Make the Most of Modern Targeted Treatments.” For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3DBvSn8. CME/MOC credit will be available until December 15, 2023.

Chair, Professor Peter Schmid, FRCP, MD, PhD, Carlos H. Barrios, MD, Eva M. Ciruelos, MD, PhD, and Hope S. Rugo, MD, FASCO, discuss Breast Cancer in this CME/MOC activity titled “TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal: Advancing Patient-Centered Care to Make the Most of Modern Targeted Treatments.” For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3DBvSn8. CME/MOC credit will be available until December 15, 2023.

Anúncio
Anúncio

Mais Conteúdo rRelacionado

Mais de PVI, PeerView Institute for Medical Education (20)

Anúncio

×